Phase 3 Study of STN1011402 ophthalmic cream in Patients With Allergic Conjunctivitis
Phase 3
- Conditions
- Allergic Conjunctivitis
- Registration Number
- JPRN-jRCT2031210639
- Lead Sponsor
- Kayoko Sakamoto
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Provided signed, written informed consent.
Has a positive result from a Type I allergy test.
Exclusion Criteria
Eye disease other than allergic conjunctivitis is present and requires treatment.
Females who are pregnant, nursing or planning a pregnancy, or females of childbearing potential who are not using a reliable method of contraception.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety, Efficacy(Subjective Ocular Symptom Score)
- Secondary Outcome Measures
Name Time Method